Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release while Breastfeeding

Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release while breastfeeding. We will also discuss about common side effects and warnings associated with Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release.

What is Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release ?


temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing itchy, watery eyes runny nose itching of the nose or throat temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily restores freer breathing through the nose

Purpose: Active ingredient (in each tablet) Purpose Loratadine 5 mg Antihistamine Pseudoephedrine sulfate 120 mg Nasal decongestant

Can I use Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release while breastfeeding?

Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release low risk for breastfeeding
Loratadine and Pseudoephedrine sulfate are the two main ingredients of Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release. Based on our individual analysis of Loratadine and Pseudoephedrine sulfate we can safely say that Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release has low risk while breastfeeding. Below we have summarized the usage of Loratadine and Pseudoephedrine sulfate while breastfeeding, we recommend you to go through it for better understanding of your usage.

Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release Breastfeeding Analsys


Loratadine while Breastfeeding

Safe

CAS Number: 79794-75-5

Second generation anti-histaminic drug with low sedative effect. Excreted in non-significant amount into breast milk. No side effects were observed in breastfed infants of treated mothers. The British Society of Immunology and Allergy rates it compatible with breastfeeding. The American Academy of Pediatrics rates it compatible with breastfeeding.

Pseudoephedrine sulfate while Breastfeeding

Low Risk

CAS Number: 90-82-4

Marketed on multiple compounds as a constituent of antitussives, mucolytics, expectorants and nasal decongestants (Nice 2000).Simple formulations (one active ingredient per drug) are preferable even more while breastfeeding. It is excreted into breast milk in a clinically non-significant amount (Findlay 1984, Kanfer 1993, Nice 2000, Aljazaf 2003) without major problems having been reported in infants whose mothers had received this medication (Ito 1993, Aljazaf 2003, Soasan 2014). Two infants out of ten appeared with mild irritability that did not require medical care (Ito 1993) with only 4 cases related to maternal pseudoephedrine intake having been declared to the French Pharmaceutical Surveillance Database in 26 years (Soasan 2014) . According to one author, it may decrease the milk production, hence a high intake of fluids is recommended to the mother (Nice 2000). Pseudoephedrine produced a variable and non-significant decrease on prolactin levels along with a variable decrease (between 3% and 59%, on average 25%, and a median 15%) on milk production in 8 women whose infants were beyond neonatal period (Aljazaf 2003).Based on the latter single work (Aljazaf 2003), it has been speculated with the use of pseudoephedrine to treat hypergalactia, galactorrhea and to inhibit milk production (Eglash 2014, Trimeloni 2016). Nor-pseudoephedrine was found in the urine of infants whose mothers had consumed a stimulant plant called Catha edulis o cat (Kristiansson 1987). Although not recommended during lactation by some authors (Rubin 1986, Amir 2011), others think it is compatible (Findlay 1984, Ghaeli 1993, Ito 1993, Mitchell 1999, Nice 2000). The American Academy of Pediatrics considers it to be a medication usually compatible with breastfeeding (AAP 2001). It is suggested the use of a lowest effective dose as possible avoiding a long-term use. Monitor milk production, especially if associated with use of Triprolidine (see specific info) during the neonatal period.


Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release Breastfeeding Analsys - 2


Loratadine while Breastfeeding

CAS Number: 79794-75-5

Because of its lack of sedation and low milk levels, maternal use of loratadine would not be expected to cause any adverse effects in breastfed infants. Loratadine might have a negative effect on lactation, especially in combination with a sympathomimetic agent such as pseudoephedrine. The British Society for Allergy and Clinical Immunology recommends loratadine at its lowest dose as a preferred choice if an antihistamine is required during breastfeeding.[1]

Pseudoephedrine sulfate while Breastfeeding

CAS Number: 90-82-4

Although the small amounts of pseudoephedrine in breastmilk are unlikely to harm the nursing infant, it may cause irritability occasionally. A single dose of pseudoephedrine decreases milk production acutely and repeated use seems to interfere with lactation. Mothers with newborns whose lactation is not yet well established or in mothers who are having difficulties producing sufficient milk should not receive pseudoephedrine. A treatment scheme has been reported for mothers with hypergalactia that uses pseudoephedrine to decrease milk supply.[1]



What should I do if already breastfed my kid after using Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release?

Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release so you should inform him based on your convenience.


My doctor has prescribed me Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release, what should I do?

Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.


If I am using Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release, will my baby need extra monitoring?

Not much monitoring required while using Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release


Who can I talk to if I have questions about usage of Claritin-d 12 Hour | Loratadine And Pseudoephedrine Sulfate Tablet, Extended Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week